Alexipharmic Drug Market Share, Trends & Forecast by 2034

Q: What is the Sales Forecast for Alexipharmic Drugs through 2034?

The market is expected to reach US$ 6.50 billion by 2034. Read Report

Request Methodology

Alexipharmic Drug Market Outlook from 2024 to 2034

Opioid overdose has become a major problem for governments in developing and developed countries, especially in the United States and the United Kingdom. With the surging number of governments legalizing prescription opioids, the risk of opioid abuse too rises.

This has pushed the demand for alexipharmic drugs. The alexipharmic drug market valuation is estimated to be a staggering US$ 3.80 billion in 2024 and is slated to reach US$ 6.50 billion by the end of 2034, growing at a decent CAGR of 5.40%.

Attributes	Details
Market Value for 2024	US$ 3.80 billion
Projected Market Value for 2034	US$ 6.50 billion
Value-based CAGR of the Market for 2024 to 2034	5.40%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Alexipharmic Drug Industry Restraints

Internationally, the market is filled with counterfeit drugs and medications. This has made the general populace reluctant to buy these drugs in some parts of the world.
Ever-evolving government policies have also become one of the major challenges in front of manufacturers.

Comparative View of Adjacent Markets

The rising disposable income among the younger generation and their desire to lead a Western lifestyle has naturally generated an excellent demand for medications and solutions that relieve people from alcohol or opioid overdose.

The growth rates of the alcohol use disorder treatment market and the alcoholic hepatitis treatment market, along with their challenges and ongoing trends, have been jotted down below.

Based on these analytics, it can be confidently projected that the alcoholic hepatitis treatment market is likely to have a more promising future in comparison to the other two.

Alexipharmic Drug Market:

Attributes	Alexipharmic Drug Market
Value-based CAGR (2024 to 2034)	5.40%
Projected Market Value (2024)	US$ 3.80 billion
Growth Factor	Growing number of people, especially those living in urban and semi-urban parts of the world, are realizing the benefits of these counterpoisons primarily through social media and government campaigns
Restraint	Lack of availability of these drugs in underdeveloped and developing areas due to low consumer demand and high price
Trend	Companies collaborating with government bodies to effectively spread awareness about alexipharmic drugs

Alcohol Use Disorder Treatment Market:

Attributes	Alcohol Use Disorder Treatment Market
Value-based CAGR (2024 to 2034)	6.4%
Growth Factor	Increased government support, such as an increase in initiatives to improve consumer awareness about drug addiction, is likely to drive the market
Restraint	Lack of knowledge of viable pharmacological therapy for AUD, particularly in emerging and underdeveloped nations
Trend	Effective marketing strategies through social media campaigns and television ads increase the significance of these treatments

Alcoholic Hepatitis Treatment Market:

Attributes	Alcoholic Hepatitis Treatment Market
Value-based CAGR (2024 to 2034)	6.5%
Growth Factor	As more people consume alcohol, and in higher quantities, the incidence of liver diseases such as alcoholic hepatitis has been on rise
Restraints	Cost of treatment for alcoholic hepatitis can be high, particularly for advanced cases that require hospitalization or liver transplantation. Limited access to treatment for some patients, particularly in developing and underdeveloped economies
Trends	Advancements in technology in liver disease treatment are expected to provide new and improved treatment options for patients with alcoholic hepatitis

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

Consumers are Increasingly Preferring Alexipharmic Drugs for Opioid Overdose

Alexipharmic drugs are used for various purposes, such as opioid overdose, alcohol overdose, benzodiazepine overdose, etc. Among these, opioid overdose is in line to hold a majority market share of 39% in 2024.

Attributes	Details
Application	Opioid Overdose
Market Share (2024)	39%

Increased awareness among the general population about the opioid crisis and the importance of having access to naloxone and other counterpoisons have significantly impacted the market growth.

The effectiveness of counterpoisons like naloxone is also pushing consumers to prefer them for opioid overdose situations. With time and tide, the stigma around the use of counterpoisons has also made consumers more comfortable in using these drugs without being frowned upon.

Hospital Pharmacies are still the Number One Sales Channel for Alexipharmic Drugs

With the growing demand for counterpoisons in the general public, manufacturers are targeting various distribution channels for the sales of these drugs. Based on this, hospital pharmacies are poised to hold a majority share of 42% in this market in 2024.

Attributes	Details
Distribution Channel	Hospital Pharmacies
Market Share (2024)	42%

Hospital pharmacies are the number one destination for counterpoisons as they are often the first point of contact for individuals experiencing severe drug overdoses. Apart from this, medical professionals prescribe counterpoisons, which are seldom found outside of hospital pharmacies.

These hospital pharmacies are also generating huge demand for these drugs as they are closely integrated with other clinical services, including emergency departments and intensive care units.

Country-wise Insights

Countries	CAGR (2024 to 2034)
South Korea	8.00%
Japan	7.10%
United Kingdom	6.70%
China	6.30%
United States	5.70%

South Korea’s Alexipharmic Drug Market to Benefit from Government’s Active Support

The market in South Korea is slated to grow at a CAGR of 8.00% through 2034. The government has been actively implementing various initiatives to mitigate the rising cases of alcohol and opioid overuse. For this, they have been promoting various counterpoisons such as naloxone.

The government’s support in the form of awareness campaigns, training, and accessibility, has created a conducive environment for the increasing adoption of counterpoisons in the country. The market is also growing in South Korea due to the increasing availability of these drugs across various distribution channels.

Rising Opioid Overdose to Profit Japan’s Alexipharmic Drug Market

The market in Japan is a promising one. It is anticipated to grow at a CAGR of 7.10% through 2034. Japan, in the last few years, has been reporting a substantial rise in opioid prescription rates, thanks to the influence of Western lifestyles on the younger generations in the country. This has created unprecedented demand for these drugs in the country.

The consumption of these drugs has also touched the skies as there has been a shift in public attitudes towards drug addiction. With increasing recognition of the need for harm reduction measures such as naloxone distribution programs, the market is set to benefit.

The United Kingdom to Exhibit Healthy Market Growth in the Near Future

The market in the United Kingdom is very likely to flourish in the coming years. The market is expected to grow at a CAGR of 6.70% through 2034. According to a survey, the opioid crisis in the United Kingdom has reached its all-time peak as opiate-related drug poisoning deaths have increased by 388% since 1993 in England and Wales.

This has significantly increased the prominence of these drugs in the United Kingdom as more people seek medications and prescriptions during emergencies associated with opioid abuse. Community distribution programs conducted by the public as well as private entities are also benefiting the consumption of these drugs in the country.

Government Regulations in China Paves the Way for Alexipharmic Drug Market

The market in China is also among the lucrative ones. It is expected to grow at a CAGR of 6.30% through 2034. The government has made strict rules and regulations regarding the manufacturing, possession, and distribution of counterpoisons in the country.

This has instilled a sense of trust in these medications among the general population in China, which is appreciably increasing the consumption of these drugs in the country. The consumption of these drugs in the Chinese marketplace is observed to be more in the urban and semi-urban settings, as compared to the rural ones.

Opioid Epidemic to Shape the Future of the United States Market

The United States alexipharmic drug market is a lucrative one. It is estimated to grow at a CAGR of 5.70% through 2034. The country is currently facing the problem of opioid addiction among the general populace.

Each year, more than 15 million people in the United States consume prescription opioids. This automatically generates huge demand for these drugs in the country as the chances of overdose are very high.

Increasing awareness among the people, coupled with rising disposable income, is a key reason for the market’s growth in the country. Modern and sophisticated infrastructure and reduced stigma regarding the use of counterpoisons among individuals are also responsible for the growth of this market in the country.

Competitive Landscape

The alexipharmic drug market is filled with a multitude of companies vying for international dominance in the marketplace. These companies, being in the pharma industry for a prolonged period of time, have extended their market reach beyond international borders.

The advent of online medicine platforms, telemedicine, and last-mile-delivery services in developed and developing countries has also helped the market to flourish in the past few years.

Recent Developments

On December 14, 2023, Novo Nordisk acquired Alkermes’s Irish plant in Athlone for US$ 92.5 million, enhancing its manufacturing capacity. Alkermes, a leading manufacturer of these drugs, aimed to meet rising demand. The deal was expected to close by mid-2024, maintaining Alkermes's royalty revenues from existing products.
On June 29, 2023, Rockwell Medical announced a 3-year co-promotional collaboration with B. Braun Medical. B. Braun's sales force promoted Rockwell's hemodialysis concentrates products on the United States West Coast. B. Braun Medical, a leading manufacturer of counterpoisons, hailed the partnership as a significant commercial opportunity.
On April 8, 2024, Bausch Health Companies Inc., a prominent manufacturer of counterpoisons, filed a patent lawsuit against Amneal Pharmaceuticals for its liver disease drug. The lawsuit ensued after Amneal sought FDA approval for a generic version of Xifaxan (rifaximin) 550 mg tablets.
On March 28, 2024, Emergent BioSolutions Inc. expanded access to OTC naloxone, addressing the opioid crisis. The leading manufacturer of counterpoisons extended NARCAN® Nasal Spray's shelf life to 48 months, distributed 22 million doses, and maintained affordability, aiding overdose prevention efforts.
Ethypharm acquired Altan Pharma on June 18, 2021, expanding into the Spanish market. Altan Pharma, a prominent manufacturer of these drugs, specializes in injectable medicines for hospitals. The acquisition bolstered Ethypharm's Critical Care portfolio and R&D pipeline.
On January 23, 2024, Emergent BioSolutions extended the shelf life of naloxone nasal spray, approved by the FDA for over-the-counter use in spring 2023, from 3 to 4 years. The extension followed the FDA's request to ensure the availability of opioid overdose reversal agents.
In December 2023, the United States government urged federal facilities nationwide to stock overdose reversal medications like naloxone, advancing efforts to combat the overdose epidemic and save lives.
In August 2016, Claris Lifesciences secured USFDA approval for its generic Flumazenil injection, used to reverse the sedative effects of benzodiazepines in the American market. The approval followed an inspection by the FDA at the same manufacturing plant.

Key Companies

Alkermes, Inc.
B. Braun Melsungen AG
Bausch Health Companies Inc.
Emergent BioSolutions
Ethypharm S.A.

Key Coverage in the Alexipharmic Drug Market

Industry trends in alexipharmic drugs
Emerging markets for alexipharmic drugs
Regulatory approvals and guidelines for alexipharmic drugs
Market penetration strategies for alexipharmic drug manufacturers
Impact of clinical trials and research studies on alexipharmic treatments’ demand

Key Segments of the Alexipharmic Drug Industry

By Application:

Alcoholic Overdose
Opioid Overdose
Benzodiazepine Overdose
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Frequently Asked Questions

How Much is the Alexipharmic Drug Market Currently Worth?

The market is expected to be worth US$ 3.80 billion in 2024.

What is the Sales Forecast for Alexipharmic Drugs through 2034?

The market is expected to reach US$ 6.50 billion by 2034.

At What Rate is the Alexipharmic Drug Market Growing?

The market is in line to grow at a CAGR of 5.40% from 2024 to 2034.

Which are the Key Companies in the Alexipharmic Drug Market?

Alkermes, Inc., B. Braun Melsungen AG, Bausch Health Companies Inc., Emergent BioSolutions, and Ethypharm S. A. are some of the major players in the market.

What was the Value of the Alexipharmic Drug Market in 2023?

The valuation for the alexipharmic drug market in 2023 was US$ 3.60 billion.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Manufacturer

3.5.1.2. Mid-Level Participants (Traders)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Application, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Application, 2024 to 2034

5.3.1. Alcoholic Overdose

5.3.2. Opioid Overdose

5.3.3. Benzodiazepine Overdose

5.3.4. Others

5.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Distribution Channel, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Distribution Channel, 2024 to 2034

6.3.1. Hospital Pharmacies

6.3.2. Retail Pharmacies

6.3.3. Online Pharmacies

6.3.4. Others

6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023

7.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

8.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

8.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

8.2.1. By Country

8.2.1.1. USA

8.2.1.2. Canada

8.2.2. By Application

8.2.3. By Distribution Channel

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Application

8.3.3. By Distribution Channel

8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Application

9.2.3. By Distribution Channel

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Application

9.3.3. By Distribution Channel

9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. UK

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Application

10.2.3. By Distribution Channel

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Application

10.3.3. By Distribution Channel

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Application

11.2.3. By Distribution Channel

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Application

11.3.3. By Distribution Channel

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Application

12.2.3. By Distribution Channel

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Application

12.3.3. By Distribution Channel

12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Application

13.2.3. By Distribution Channel

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Application

13.3.3. By Distribution Channel

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Application

14.2.3. By Distribution Channel

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Application

14.3.3. By Distribution Channel

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. USA

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2023

15.1.2.1. By Application

15.1.2.2. By Distribution Channel

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2023

15.2.2.1. By Application

15.2.2.2. By Distribution Channel

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2023

15.3.2.1. By Application

15.3.2.2. By Distribution Channel

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2023

15.4.2.1. By Application

15.4.2.2. By Distribution Channel

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2023

15.5.2.1. By Application

15.5.2.2. By Distribution Channel

15.6. UK

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2023

15.6.2.1. By Application

15.6.2.2. By Distribution Channel

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2023

15.7.2.1. By Application

15.7.2.2. By Distribution Channel

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2023

15.8.2.1. By Application

15.8.2.2. By Distribution Channel

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2023

15.9.2.1. By Application

15.9.2.2. By Distribution Channel

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2023

15.10.2.1. By Application

15.10.2.2. By Distribution Channel

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2023

15.11.2.1. By Application

15.11.2.2. By Distribution Channel

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2023

15.12.2.1. By Application

15.12.2.2. By Distribution Channel

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2023

15.13.2.1. By Application

15.13.2.2. By Distribution Channel

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2023

15.14.2.1. By Application

15.14.2.2. By Distribution Channel

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2023

15.15.2.1. By Application

15.15.2.2. By Distribution Channel

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2023

15.16.2.1. By Application

15.16.2.2. By Distribution Channel

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2023

15.17.2.1. By Application

15.17.2.2. By Distribution Channel

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2023

15.18.2.1. By Application

15.18.2.2. By Distribution Channel

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2023

15.19.2.1. By Application

15.19.2.2. By Distribution Channel

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2023

15.20.2.1. By Application

15.20.2.2. By Distribution Channel

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2023

15.21.2.1. By Application

15.21.2.2. By Distribution Channel

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2023

15.22.2.1. By Application

15.22.2.2. By Distribution Channel

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2023

15.23.2.1. By Application

15.23.2.2. By Distribution Channel

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Application

16.3.3. By Distribution Channel

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Alkermes, Inc.

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. B. Braun Melsungen AG

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. Bausch Health Companies Inc.

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. Emergent BioSolutions

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. Ethypharm S. A.

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. Fresenius SE & Co. KGaA

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. Hikma Pharmaceuticals

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. Merck & Co., Inc.

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. Mylan N.V.

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

17.1.10. SGPharma Pvt. Ltd.

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.10.5.2. Product Strategy

17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Unit Pack) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 4: Global Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 6: Global Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: North America Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 10: North America Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 12: North America Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Latin America Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 15: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 16: Latin America Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 18: Latin America Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: Western Europe Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 21: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 22: Western Europe Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 23: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 24: Western Europe Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Eastern Europe Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 27: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 28: Eastern Europe Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 29: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 30: Eastern Europe Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: South Asia and Pacific Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 34: South Asia and Pacific Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 36: South Asia and Pacific Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 38: East Asia Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 39: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 40: East Asia Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 41: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 42: East Asia Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 44: Middle East and Africa Market Volume (Unit Pack) Forecast by Country, 2019 to 2034

Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 46: Middle East and Africa Market Volume (Unit Pack) Forecast by Application, 2019 to 2034

Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 48: Middle East and Africa Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034

List of Charts

Figure 1: Global Market Value (US$ Million) by Application, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Volume (Unit Pack) Analysis by Region, 2019 to 2034

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 8: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 9: Global Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 10: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 11: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 12: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 13: Global Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 14: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 15: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 16: Global Market Attractiveness by Application, 2024 to 2034

Figure 17: Global Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 18: Global Market Attractiveness by Region, 2024 to 2034

Figure 19: North America Market Value (US$ Million) by Application, 2024 to 2034

Figure 20: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 21: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 23: North America Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 26: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 27: North America Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 28: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 29: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 30: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 31: North America Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 34: North America Market Attractiveness by Application, 2024 to 2034

Figure 35: North America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 36: North America Market Attractiveness by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) by Application, 2024 to 2034

Figure 38: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 39: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 41: Latin America Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 44: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 45: Latin America Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 48: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 49: Latin America Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 50: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 52: Latin America Market Attractiveness by Application, 2024 to 2034

Figure 53: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 56: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 57: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 59: Western Europe Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 62: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 63: Western Europe Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 66: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 67: Western Europe Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 68: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 70: Western Europe Market Attractiveness by Application, 2024 to 2034

Figure 71: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 73: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 74: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 77: Eastern Europe Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 81: Eastern Europe Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 85: Eastern Europe Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 88: Eastern Europe Market Attractiveness by Application, 2024 to 2034

Figure 89: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 91: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034

Figure 92: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: South Asia and Pacific Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 99: South Asia and Pacific Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 103: South Asia and Pacific Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 106: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034

Figure 107: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 109: East Asia Market Value (US$ Million) by Application, 2024 to 2034

Figure 110: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 111: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 113: East Asia Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 116: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 117: East Asia Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 118: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 120: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 121: East Asia Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 122: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 123: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 124: East Asia Market Attractiveness by Application, 2024 to 2034

Figure 125: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 127: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034

Figure 128: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 131: Middle East and Africa Market Volume (Unit Pack) Analysis by Country, 2019 to 2034

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 135: Middle East and Africa Market Volume (Unit Pack) Analysis by Application, 2019 to 2034

Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 139: Middle East and Africa Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034

Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 142: Middle East and Africa Market Attractiveness by Application, 2024 to 2034

Figure 143: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

April 2024

REP-GB-19529

318 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Alexipharmic Drug Market

Alexipharmic Drug Market Forecast by Alcoholic and Opioid Overdose for 2024 to 2034